Technical Analysis for TSBX - Turnstone Biologics Corp.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 20 DMA | Bearish | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
50 DMA Resistance | Bearish | -3.83% | |
Expansion Pivot Sell Setup | Bearish Swing Setup | -3.83% | |
20 DMA Support | Bullish | -3.83% | |
Bollinger Band Squeeze | Range Contraction | -3.83% | |
50 DMA Resistance | Bearish | -8.91% | |
Spinning Top | Other | -8.91% |
Alert | Time |
---|---|
Down 3% | about 11 hours ago |
Down 2 % | about 11 hours ago |
Possible NR7 | about 11 hours ago |
Possible Inside Day | about 11 hours ago |
60 Minute Opening Range Breakdown | about 14 hours ago |
Get a Trading Assistant
- Earnings date: 02/28/2024
Turnstone Biologics Corp. Description
Turnstone Biologics is a clinical-stage biotechnology company developing new medicines to treat and cure solid tumors by pioneering a differentiated approach to TIL therapy. Turnstone’s innovative TIL therapy is based upon the identification, selection, and expansion of the most potent tumor-reactive T cells, known as Selected TILs, and is designed to overcome the limitations of first-generation bulk TILs that have demonstrated objective responses only in limited tumor types. Turnstone’s most advanced program, TIDAL-01, is currently being evaluated in two Phase 1 studies in patients with melanoma, breast cancer, and colorectal cancer, and the Company is also actively advancing its preclinical pipeline programs including TIDAL-02, its next Selected TIL program, and its TIDAL-01 and viral immunotherapy combination program.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Solid Tumors Immunotherapy Breast Cancer Melanoma Colorectal Cancer Tumor Infiltrating Lymphocytes
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 13.2 |
52 Week Low | 1.625 |
Average Volume | 177,218 |
200-Day Moving Average | 4.01 |
50-Day Moving Average | 3.02 |
20-Day Moving Average | 2.86 |
10-Day Moving Average | 2.94 |
Average True Range | 0.34 |
RSI (14) | 45.65 |
ADX | 16.91 |
+DI | 18.01 |
-DI | 19.01 |
Chandelier Exit (Long, 3 ATRs) | 2.37 |
Chandelier Exit (Short, 3 ATRs) | 3.48 |
Upper Bollinger Bands | 3.27 |
Lower Bollinger Band | 2.46 |
Percent B (%b) | 0.37 |
BandWidth | 28.02 |
MACD Line | -0.02 |
MACD Signal Line | -0.03 |
MACD Histogram | 0.0111 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 3.15 | ||||
Resistance 3 (R3) | 3.17 | 3.06 | 3.09 | ||
Resistance 2 (R2) | 3.06 | 2.96 | 3.05 | 3.06 | |
Resistance 1 (R1) | 2.91 | 2.90 | 2.86 | 2.89 | 3.04 |
Pivot Point | 2.80 | 2.80 | 2.77 | 2.79 | 2.80 |
Support 1 (S1) | 2.65 | 2.70 | 2.60 | 2.63 | 2.48 |
Support 2 (S2) | 2.54 | 2.64 | 2.53 | 2.46 | |
Support 3 (S3) | 2.39 | 2.54 | 2.44 | ||
Support 4 (S4) | 2.37 |